Articles Tagged With:
-
Tranexamic Acid and Outcomes in Patients with Moderate or Severe TBI
In this randomized, placebo-controlled trial using tranexamic acid to treat patients with moderate or severe traumatic brain injury within two hours of injury, there was no significant difference between treatment groups in either mortality or functional recovery at six months.
-
IqYmune for CIDP
IqYmune is a highly purified 10% concentration of human immunoglobulin obtained from healthy volunteers. It appears to have similar efficacy in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) as conventional intravenous immunoglobulin, with 76% of the study patients showing a significant improvement in a standardized disability score.
-
COVID-19 Infection in MS Patients
In a multicenter, retrospective analysis of patients in a multiple sclerosis (MS) registry, the authors described the clinical characteristics and risks associated with severity of complications from COVID-19 infection in patients with MS.
-
Ketamine for Super-Refractory Status Epilepticus
In this retrospective paper, the authors review the efficacy and safety of ketamine infusion in patients with status epilepticus who have failed benzodiazepine, standard anticonvulsant, and at least one other anesthetic drip.
-
Study of Epidural Analgesia Stirs Controversy
Several groups stand in strong opposition to a group of researchers’ recent conclusion about possible connection to autism risk.
-
Mozart Therapy for Epilepsy
A randomized, controlled, crossover trial in adult patients with drug-resistant epilepsy compared listening to a Mozart piano sonata daily to an active control. It showed reduction in seizures during the Mozart treatment compared to both baseline and the control treatment.
-
Scrambler Therapy for Neuromyelitis Optica Pain Treatment
Scrambler therapy appears to significantly reduce central neuropathic pain for patients with neuromyelitis optica spectrum disorder, although pain reduction is not shown to be sustained for more than 30 days after treatment.
-
Health Insurance Competition, Choice Declining in Many U.S. Markets
Annual analysis revealed commercial insurance became more concentrated between 2014 and 2019.
-
Ketamine Use in Emergency Medicine
Ketamine is a medication traditionally used by emergency physicians for intubation and procedural sedation. This article will discuss many common and accepted uses of ketamine, primarily for agitation, rapid sequence intubation (RSI), sedation, and pain management.
-
Diagnosis and Management of Supraventricular Tachycardia
Supraventricular tachycardia (SVT) is a common medical condition. Diagnosis and treatment often occur simultaneously. To a great degree, long-term treatment options depend on the history of symptoms and the patient’s desire, rather than on the specific type of SVT.